Skip to content

The so-called ‘forever chemicals’ can stick around in the environment — and in our bodies. Scientists agree there is cause for concern. So what should we be doing to mitigate our health risks?

The so-called ‘forever chemicals’ can stick around in the environment — and in our bodies. Scientists agree there is cause for concern. So what should we be doing to mitigate our health risks?

Many women experience extreme mood fluctuations as they approach menopause. Stanford Medicine’s Karen Adams says knowledge and access are key to aiding this normal condition.

Many women experience extreme mood fluctuations as they approach menopause. Stanford Medicine’s Karen Adams says knowledge and access are key to aiding this normal condition.

Using AI, continuous glucose monitors, and an equity approach, diabetes care could be saving many more lives, Stanford Medicine researchers say.

Using AI, continuous glucose monitors, and an equity approach, diabetes care could be saving many more lives, Stanford Medicine researchers say.

By further segmenting study results, Stanford Medicine’s Irogue Igbinosa and collaborators have begun to tease out important health differences between different subsets of the population.

By further segmenting study results, Stanford Medicine’s Irogue Igbinosa and collaborators have begun to tease out important health differences between different subsets of the population.

A new test can detect the biological signature of Parkinson’s disease before symptoms arise. A Stanford Medicine neurologist explains why early diagnosis opens the door to better therapies.

A new test can detect the biological signature of Parkinson’s disease before symptoms arise. A Stanford Medicine neurologist explains why early diagnosis opens the door to better therapies.

Published on

A few closely related drugs, all squarely aimed at treating Alzheimer’s disease, have served up what can be charitably described as a lackadaisical performance. Stanford Medicine neurologist Mike Greicius explains why these drugs, so promising in theory, don’t appear to be helping patients much if at all.

A few closely related drugs, all squarely aimed at treating Alzheimer’s disease, have served up what can be charitably described as a lackadaisical performance. Stanford Medicine neurologist Mike Greicius explains why these drugs, so promising in theory, don’t appear to be helping patients much if at all.

Many social determinants of health can influence a patient’s risk, but Palaniappan and fellow researchers have noticed, from working with data from patients around the nation, that race is not among the most accurate or equitable.

Many social determinants of health can influence a patient’s risk, but Palaniappan and fellow researchers have noticed, from working with data from patients around the nation, that race is not among the most accurate or equitable.

Quenton Rashawn Bubb continues to value the complex, complementary nature of work on parallel paths -- not just as a musician/academic, but now on the path to his career.

Quenton Rashawn Bubb continues to value the complex, complementary nature of work on parallel paths -- not just as a musician/academic, but now on the path to his career.

Improvements in treatment technology are helping physicians deliver individualized care to their Type 1 diabetes patients.

Improvements in treatment technology are helping physicians deliver individualized care to their Type 1 diabetes patients.

Published on

The cost of branded pharmaceuticals and quality and availability of generic versions are two key issues facing the U.S. marketplace.

The cost of branded pharmaceuticals and quality and availability of generic versions are two key issues facing the U.S. marketplace.

Published on

Researchers compared diets and found that some people responded better to different types of nutrition when it comes to weight loss.

Researchers compared diets and found that some people responded better to different types of nutrition when it comes to weight loss.